The company secures Beta (Market Risk) of -0.6136 which conveys that as returns on market increase, returns on owning Navidea Biopharmaceutica are expected to decrease at a much smaller rate. During bear market, Navidea Biopharmaceutica is likely to outperform the market. Although it is extremely important to respect Navidea Biopharmaceutica price patterns
, it is better to be realistic regarding the information on equity historical price patterns
. The philosophy towards estimating future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators
. By analyzing Navidea Biopharmaceutica technical indicators
you can presently evaluate if the expected return of 0.0% will be sustainable into the future. Navidea Biopharmaceutica
right now secures a risk of 0.0%. Please verify Navidea Biopharmaceuticals Treynor Ratio
, Value At Risk
, Downside Variance
, as well as the relationship
between Maximum Drawdown
and Potential Upside
to decide if Navidea Biopharmaceuticals will be following its current price movements.
Over the last 30 days Navidea Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Navidea Biopharmaceutica is not utilizing all of its potentials. The current stock price disturbance, may contribute to short term losses for the investors.
|Fifty Two Week Low||43.00|
|Fifty Two Week High||50.50|